---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-073418"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:25:50.305612+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics transitions COO Jack Syage to Chief Scientific Officer

## Summary
- Jack Syage, previously President and COO, appointed Chief Scientific Officer effective June 17, 2024.
- Syage retains President title and reports to CEO James Sapirstein; compensation unchanged.
- Chief Operating Officer role vacated; no replacement named.

## SEC filing metadata
- accession: 0001104659-24-073418
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924073418/0001104659-24-073418-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924073418/tm2417688d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-073418
- JSON: https://secwatch.observer/filing/0001104659-24-073418.json
- Plain text: https://secwatch.observer/filing/0001104659-24-073418.txt

## Key facts
- Executive change
  Jack Syage changed role as Chief Scientific Officer at GridAI Technologies Corp..
  - Action: transitioned
  - Role: Chief Scientific Officer
  source text: transitioned Dr. Syage from the role of Chief Operating Officer to the newly appointed role of Chief Scientific Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465924073418/0001104659-24-073418-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.